Environmental enteropathy: Critical implications of a poorly understood condition

Trends in Molecular Medicine

Volumn 18, Issue 6, 2012, Pages 328-336

  Korpe, Poonum S ^a   Petri, William A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Environmental enteropathy; Fecal oral contamination; Malnutrition; Mucosal immunity; Oral vaccine failure; Stunting; Tropical enteropathy

Indexed keywords

CALGRANULIN; CITRULLINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; INTERLEUKIN 15; LACTOFERRIN; MYELOPEROXIDASE; NEOPTERIN; PROTEIN S 100; PROTEIN S 100 A12; RNA 16S; TETRACYCLINE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; XYLOSE;

ANTIBIOTIC THERAPY; BACTERIAL TRANSLOCATION; CELIAC DISEASE; CELL INFILTRATION; CITROBACTER RODENTIUM; CYTOKINE PRODUCTION; ENTEROPATHY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; ENVIRONMENTAL ENTEROPATHY; GENETIC PREDISPOSITION; GLUTEN FREE DIET; HUMAN; IMMUNOSTIMULATION; INFLAMMATORY CELL; INTESTINE CRYPT; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; MALNUTRITION; MUCOSAL IMMUNITY; NUTRITIONAL HEALTH; PATHOGENESIS; REVIEW; SANITATION;

ANIMALS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ENVIRONMENT; HUMANS; INTESTINAL DISEASES; MALABSORPTION SYNDROMES; T-LYMPHOCYTES;

EID: 84861879505     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.04.007     Document Type: Review

References (82)

1. Solón P. The Human Right to Water and Sanitation 28 July 2010, 64th General Assembly Plenary, United Nations, New York.
2. Ramakrishna B.S., et al. Tropical malabsorption. Postgrad. Med. J. 2006, 82:779-787.
3. Sullivan P.B., et al. Chronic diarrhea and malnutrition - histology of the small intestinal lesion. J. Pediatr. Gastroenterol. Nutr. 1991, 12:195-203.
4. Dewey K.G., Adu-Afarwuah S. Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Mater. Child Nutr. 2008, 4(Suppl. 1):24-85.
5. Prentice A. Nutrient requirements for growth, pregnancy, and lactation: the Keneba experience. S. Afr. J. Clin. Nutr. 1993, 6:33-38.
6. Bhutta Z.A., et al. What works? Interventions for maternal and child undernutrition and survival. Lancet 2008, 371:417-440.
7. Hasan A.S., et al. Antibody levels against polioviruses in children following pulse polio immunization program. Indian Pediatr. 2004, 41:1040-1044.
8. Naik T.N., Krishnan T. Rotavirus vaccine: current status & future prospects. Indian J. Med. Res. 1996, 104:76-85.
9. Ratnaswamy L., et al. Paralytic poliomyelitis: clinical and virological studies. Indian Pediatr. 1973, 10:443-447.
10. Levine M.M. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol. 2010, 8:129.
11. Sprinz H., et al. Biopsy of small bowel of Thai people. With special reference to recovery from Asiatic cholera and to an intestinal malabsorption syndrome. Am. J. Clin. Pathol. 1962, 38:43-51.
12. Cook G.C., et al. Jejunal morphology of the African in Uganda. J. Pathol. 1969, 98:157-169.
13. Lindenbaum J., et al. Subclinical small-intestinal disease in East Pakistan. Br. Med. J. 1966, 2:1616-1619.
14. Cowell E.J., et al. Jejunal morphological characteristics in South Vietnamese residents. JAMA 1968, 206:2273.
15. Garcia S. Malabsorption and malnutrition in Mexico. Am. J. Clin. Nutr. 1968, 21:1066-1076.
16. Lindenbaum J., et al. Recovery of small-intestinal structure and function after residence in the tropics. I. Studies in peace corps volunteers. Ann. Intern. Med. 1971, 74:218-222.
17. Lindenbaum J. Small intestine dysfunction in Pakistanis and Americans resident in Pakistan. Am. J. Clin. Nutr. 1968, 21:1023-1029.
18. Lindenbaum J., et al. Subclinical malabsorption in developing countries. Am. J. Clin. Nutr. 1972, 25:1056-1061.
19. Stanfield J.P., et al. Intestinal biopsy in kwashiorkor. Lancet 1965, 2:519-523.
20. Fagundes-Neto U. Tropical enteropathy (environmental enteropathy) in early childhood: a syndrome caused by contaminated environment. J. Trop. Pediatr. 1984, 30:204-209.
21. Kelly P., et al. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am. J. Trop. Med. Hyg. 2004, 70:412-419.
22. Patriarca P.A., et al. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev. Infect. Dis. 1991, 13:926-939.
23. Lunn P.G. The impact of infection and nutrition on gut function and growth in childhood. Proc. Nutr. Soc. 2000, 59:147-154.
24. Mathan V.I., Baker S.J. An epidemic of tropical sprue in southern India. I. Clinical features. Ann. Trop. Med. Parasitol. 1970, 64:439-451.
25. Trier J.S., Donnelly S.M. Case 15 - 1990 - A 78-year-old woman from the Dominican Republic with chronic diarrhea. N. Engl. J. Med. 1990, 322:1067-1075.
26. Batheja M.J., et al. The face of tropical sprue in 2010. Case Rep. Gastroenterol. 2010, 4:168-172.
27. Khin-Maung U., et al. Epidemiology of small bowel bacterial overgrowth and rice carbohydrate malabsorption in Burmese (Myanmar) village children. Am. J. Trop. Med. Hyg. 1992, 47:298-304.
28. dos Reis J.C., et al. Breath hydrogen test in the diagnosis of environmental enteropathy in children living in an urban slum. Dig. Dis. Sci. 2007, 52:1253-1258.
29. Trehan I., et al. A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am. J. Gastroenterol. 2009, 104:2326-2333.
30. Fagundes Neto U., et al. Asymptomatic environmental enteropathy among slum-dwelling infants. J. Am. Coll. Nutr. 1994, 13:51-56.
31. Sullivan P.B., et al. Persistent diarrhea and malnutrition - the impact of treatment on small bowel structure and permeability. J. Pediatr. Gastroenterol. Nutr. 1992, 14:208-215.
32. Campbell D.I., et al. Chronic T cell-mediated enteropathy in rural West African children: relationship with nutritional status and small bowel function. Pediatr. Res. 2003, 54:306-311.
33. Schuppan D., et al. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
34. Veitch A.M., et al. Tropical enteropathy: a T-cell-mediated crypt hyperplasia enteropathy. Eur. J. Gastroenterol. Hepatol. 2001, 13:1175-1181.
35. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
36. Jiang W., et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 2009, 199:1177-1185.
37. Strutz F., et al. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med. 1999, 25:435-444.
38. Cassol E., et al. Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J. Infect. Dis. 2010, 202:723-733.
39. Nowroozalizadeh S., et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J. Infect. Dis. 2010, 201:1150-1154.
40. Redd A.D., et al. Is microbial translocation a cause or consequence of HIV disease progression? J. Infect. Dis. 2011, 203:744-745.
41. Redd A.D., et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6718-6723.
42. Ivanov I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
43. Kane M., et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science 2011, 334:245-249.
44. Kuss S., et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011, 334:249-252.
45. Ince M.N., et al. Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGF beta after lipopolysaccharide stimulation. J. Immunol. 2006, 176:726-729.
46. Metwali A., et al. Induction of CD8+ regulatory T cells in the intestine by Heligmosomoides polygyrus infection. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G253-G259.
47. Summers R., et al. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol. 2003, 98:2034-2041.
48. Luong T.V. Prevention of Intestinal Worm Infections through Improved Sanitation and Hygiene 2002, UNICEF East Asia and Pacific Regional Office.
49. Juby L.D., et al. Lactulose/mannitol test: an ideal screen for celiac disease. Gastroenterology 1989, 96:79-85.
50. Camilleri M., et al. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol. Motil. 2010, 22:e15-e26.
51. Lunn P.G., et al. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 1991, 338:907-910.
52. Campbell D.I., et al. Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J. Nutr. 2003, 133:1332-1338.
53. Tibble J.A., et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000, 47:506-513.
54. Tibble J.A., et al. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002, 123:450-460.
55. Penalva J.C., et al. A study of intestinal permeability in relation to the inflammatory response and plasma endocab IgM levels in patients with acute pancreatitis. J. Clin. Gastroenterol. 2004, 38:512-517.
56. Crenn P., et al. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003, 124:1210-1219.
57. Papadia C., et al. Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population. Clin. Nutr. 2010, 29:795-800.
58. Lima A., et al. Intestinal barrier function and weight gain in malnourished children taking glutamine supplemented enteral formula. J. Pediatr. Gastroenterol. Nutr. 2005, 40:28-35.
59. Sullivan P.B. Studies of the small intestine in persistent diarrhea and malnutrition: the Gambian experience. J. Pediatr. Gastroenterol. Nutr. 2002, 34:S11-S13.
60. Sheehy T.W., et al. Hookworm disease and malabsorption. Gastroenterology 1962, 42:148-156.
61. Pickering A.J., et al. Efficacy of alcohol-based hand sanitizer on hands soiled with dirt and cooking oil. J. Water Health 2011, 9:429-433.
62. Dobe M., et al. Sanitation: the hygienic means of promoting health. Indian J. Public Health 2011, 55:49-51.
63. Costa L.B., et al. Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model. J. Parasitol. 2011, 97:1113-1120.
64. Wang W., et al. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell. Sci. 2000, 113:4435-4440.
65. Fasano A., et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000, 355:1518-1519.
66. Wood G.M., et al. Small bowel morphology in British Indian and Afro-Caribbean subjects: evidence of tropical enteropathy. Gut 1991, 32:256-259.
67. Green P.H.R. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005, 128:S74-S78.
68. Abraham C., Cho J.H. Inflammatory bowel disease. N. Engl. J. Med. 2009, 361:2066-2078.
69. Mondal D., et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin. Infect. Dis. 2012, 54:185-192.
70. Mao R., et al. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies. Inflamm. Bowel Dis. 2012, 10.1002/ibd.22861.
71. Sidler M.A., et al. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm. Bowel Dis. 2008, 14:359-366. 10.1002/ibd.20336.
72. Foell D., et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003, 52:847-853.
73. Kaiser T., et al. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 2007, 56:1706-1713.
74. Nylund C.M., et al. Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease. J. Pediatr. Gastroenterol. Nutr. 2011, 52:542-548.
75. Fuchs D., et al. Urinary neopterin in the diagnosis and follow-up of neoplasia: a biochemical parameter to detect cell-mediated immune response. Tumour Biol. 1984, 5:199-209.
76. Chu, C.C. et al. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis. J. Nutr. Biochem. doi:10.1016/j.bbr.2011.03.031.
77. Peterson K.M., et al. The expression of REG1A and REG1B is increased during acute amebic colitis. Parasitol. Int. 2011, 60:296-300. PMID: 21586335.
78. Planas R., et al. Regenerating gene Iα is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study. Transl. Res. 2011, 158:140-145.
79. Guerrant R.L., et al. Measurement of fecal lactoferrin as a marker for fecal leukocytes. J. Clin. Microbiol. 1992, 30:1238-1242.
80. Steiner T.L., et al. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin. Diagn. Lab. Immunol. 1997, 4:719-722.
81. Alcantara C.S., et al. Interleukin-8, tumor necrosis factor-alpha, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis. Am. J. Trop. Med. Hyg. 2003, 68:325-328.
82. Humphrey J.H. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 2009, 374:1032-1035.